Suppr超能文献

[别嘌醇与苯溴马隆单一及联合治疗。肾脏对致石物质和胶体保护物质的排泄(作者译)]

[Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].

作者信息

Mertz D P

出版信息

Med Klin. 1977 Apr 15;72(15):664-8.

PMID:857138
Abstract

12 hyperuremic male patients got during two comparative tests for 16 days 300 mg/die Allopurinol or 100 mg/die Benzbromarone or a combination of 100 mg Allopurinol with 20 mg Benzbromarone. During this time the renal elimination of uric acid, sodium, calcium, magnesium and citrate war measured and the renal clearance of uric acid, creatinine and sodium was determinated. Without any therapy the combination of 100 mg Allopurinol with 20 mg Benzbromarone per die reduces the elimination of uric acid significantly under the original value in the 24-hour-urine. The elimination of the uric acid increases with 300 mg/die Allopurinol. The clearance ratio of uric acid and creatinine rises 33% to 60%. With 100 mg/die Benzbromarone this value goes up to 233% compared with the results without therapy. At the same time the therapy with Brenzbromarone makes the clearance ratio of uric acid to sodium rise significantly to 257%. Under the 3 types of therapy there is no significant change in the 24-hours-urine of the clearance of creatinine and sodium, the clearance ratio of sodium to creatinine and the elimination ratio of sodium, calcium, magnesium and citrate. Hyperuremic patients with urolithic diathesis need Allopurinol therapy without any combination.

摘要

12名男性尿毒症患者在两项对比试验中,连续16天每天服用300毫克别嘌醇、或100毫克苯溴马隆、或100毫克别嘌醇与20毫克苯溴马隆的组合。在此期间,测量了尿酸、钠、钙、镁和柠檬酸盐的肾脏排泄情况,并测定了尿酸、肌酐和钠的肾脏清除率。在未进行任何治疗的情况下,每天服用100毫克别嘌醇与20毫克苯溴马隆的组合可使24小时尿液中尿酸的排泄量显著低于初始值。每天服用300毫克别嘌醇可使尿酸排泄量增加。尿酸与肌酐的清除率比值上升33%至60%。与未治疗的结果相比,每天服用100毫克苯溴马隆时,该值升至233%。同时,苯溴马隆治疗可使尿酸与钠的清除率比值显著升至257%。在这三种治疗方式下,24小时尿液中肌酐和钠的清除率、钠与肌酐的清除率比值以及钠、钙、镁和柠檬酸盐的排泄率均无显著变化。患有尿路结石素质的尿毒症患者需要单独使用别嘌醇治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验